We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
Cap. Flow
+$1.94B
Cap. Flow %
50.99%
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$25.6M
2
JPM icon
JPMorgan Chase
JPM
+$21.7M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.7M
4
KR icon
Kroger
KR
+$17.9M
5
TMUS icon
T-Mobile US
TMUS
+$15.8M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.3M
2
TMO icon
Thermo Fisher Scientific
TMO
+$8.42M
3
BMY icon
Bristol-Myers Squibb
BMY
+$8.34M
4
CSCO icon
Cisco
CSCO
+$8.02M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.01M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 16.54%
3 Industrials 11.45%
4 Healthcare 11.32%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AJG icon
3276
Arthur J. Gallagher & Co
AJG
$67B
– –
-1,555
Closed -$482K
ALE
3277
DELISTED
Allete
ALE
– –
-28,936
Closed -$1.92M
ALHC icon
3278
Alignment Healthcare
ALHC
$3.85B
– –
-12,127
Closed -$212K
ALSN icon
3279
Allison Transmission
ALSN
$10.1B
– –
-9,234
Closed -$784K
ALVO icon
3280
Alvotech
ALVO
$1.06B
– –
-27,246
Closed -$223K
ALXO icon
3281
ALX Oncology
ALXO
$269M
– –
-26,621
Closed -$48.7K
AMPX icon
3282
Amprius Technologies
AMPX
$1.28B
– –
-173,005
Closed -$1.82M
ANDE icon
3283
Andersons Inc
ANDE
$2.48B
– –
-6,828
Closed -$272K
ANEB
3284
DELISTED
Anebulo Pharmaceuticals
ANEB
– –
-19,153
Closed -$47.9K
ANTX icon
3285
AN2 Therapeutics
ANTX
$175M
– –
-18,541
Closed -$23.5K
ANVS icon
3286
Annovis Bio
ANVS
$71.5M
– –
-28,854
Closed -$59.7K
AON icon
3287
Aon
AON
$81.1B
– –
-3,558
Closed -$1.27M
AOS icon
3288
A.O. Smith
AOS
$8.79B
– –
-6,713
Closed -$493K
APAM icon
3289
Artisan Partners
APAM
$2.92B
– –
-10,049
Closed -$436K
APD icon
3290
Air Products & Chemicals
APD
$65.8B
– –
-2,546
Closed -$694K
APG icon
3291
APi Group
APG
$16.9B
– –
-49,499
Closed -$1.7M
APLS
3292
DELISTED
Apellis Pharmaceuticals
APLS
– –
-14,407
Closed -$326K
APLT
3293
DELISTED
Applied Therapeutics
APLT
– –
-23,579
Closed -$14.3K
APO icon
3294
Apollo Global Management
APO
$71.7B
– –
-17,246
Closed -$2.3M
APOG icon
3295
Apogee Enterprises
APOG
$873M
– –
-8,219
Closed -$358K
APP icon
3296
Applovin
APP
$141B
– –
-1,868
Closed -$1.34M
APYX icon
3297
Apyx Medical
APYX
$164M
– –
-21,545
Closed -$46.1K
AQST icon
3298
Aquestive Therapeutics
AQST
$460M
– –
-60,776
Closed -$340K
ARBK
3299
Argo Blockchain
ARBK
$41.9M
– –
-109
Closed -$6.14K
ARE icon
3300
Alexandria Real Estate Equities
ARE
$9.31B
– –
-10,064
Closed -$839K
130 131
132
133 134

Similar funds

HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return
SAM
Scopus Asset Management New York $5.77B AUM 36.85% 1-Year Est. Return
PP
Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

XTX Topco's Q4 2025 Portfolio in Review

As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.

  • XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
  • XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
  • XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
  • XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
  • XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
  • XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
  • XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.